Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Asymchem is a leading global Contract Development and Manufacturing Organization (CDMO) providing integrated solutions throughout the drug R&D and commercialization lifecycle. Headquartered in Tianjin, China, the company specializes in small molecule drug development but has significantly expanded its capabilities into biologics, peptides, oligonucleotides, and cell and gene therapies. Asymchem is globally recognized for its expertise in green chemistry and continuous flow manufacturing technologies, which enhance efficiency and sustainability in pharmaceutical production. The company serves a diverse global clientele, including major pharmaceutical giants and emerging biotech firms, supporting programs from preclinical stages through to large-scale commercial supply. With multiple R&D and manufacturing facilities across China, the United States, and Europe, Asymchem provides a robust infrastructure for global drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kelaiying Life Science Technology.